Table 2 Relationship between MCM8 expression and tumor characteristics in patients with bladder cancer
From: Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo
Features | No. of patients | MCM8 expression | P value | |
|---|---|---|---|---|
low | high | |||
All patients | 46 | 22 | 24 | |
Age (years) | 0.559 | |||
< 74 | 23 | 10 | 13 | |
≥ 74 | 23 | 12 | 11 | |
Gender | 0.056 | |||
Male | 39 | 21 | 18 | |
Female | 7 | 1 | 6 | |
Tumor size | 1.000 | |||
< 4 cm | 18 | 9 | 9 | |
≥ 4 cm | 26 | 13 | 13 | |
Lymphadenopathy | 0.206 | |||
Yes | 4 | 1 | 3 | |
No | 27 | 16 | 11 | |
Grade | 0.001 | |||
II | 16 | 13 | 3 | |
III | 30 | 9 | 21 | |
Stage | 0.334 | |||
1 | 4 | 2 | 2 | |
2 | 8 | 5 | 3 | |
3 | 12 | 7 | 5 | |
4 | 5 | 1 | 4 | |
T Infiltrate | 0.162 | |||
T1 | 8 | 5 | 3 | |
T2 | 12 | 7 | 5 | |
T3 | 16 | 6 | 10 | |
T4 | 3 | 1 | 2 | |